Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

• If you are wondering whether Mineralys Therapeutics at about US$27.60 offers fair value or not, this article will walk through what the current market price may be implying.

• The stock has had a mixed run recently, with a 13% decline over the last 7 days and a 15.7% decline over the last 30 days, yet it still stands on a 169.5% return over 1 year and 53.9% over 3 years.

• Recent attention on Mineralys has been driven largely by its positioning in the pharmaceuticals and biotech space, where investors often focus on pipeline progress, regulatory milestones and funding. These kinds of updates…